In the latest of her regular dispatches about life with breast cancer, Dina Rabinovitch is told that her disease appears to be under control - for the moment at least.
A new class of breast cancer drugs yesterday won final draft approval for use in the NHS alongside the "gold standard" Tamoxifen, which many expect them quickly to replace.